body
WHEREAS, Sickle cell disease is a genetic disorder, which affects the red blood cells and prevents oxygen from reaching the tissues. Unpredictable, repeated episodes of pain is the hallmark sign of sickle cell disease, and although promising research has been made, a cure has yet to be discovered; and,
WHEREAS, The Department of Hematology/Oncology at Children's Hospital of Pittsburgh serves nearly 300 children with sickle cell disease in the Western Pennsylvania region, the majority of which reside in the City of Pittsburgh. Through coordinated care and compassion, they have made a significant impact in the lives of the children and families suffering from sickle cell disease; and,
WHEREAS, Guided by the leadership of Lakshmanan Krishnamurti MD, Director of the Comprehensive Hemoglobinopathy Program, the Department of Hematology/Oncology at the Children's Hospital of Pittsburgh has, in the past twelve years, risen to excellence and prominence within its field; and,
WHEREAS, With a dedicated team of physicians, researchers, nurses, social workers, and support staff, the Sickle Cell Team have become national leaders for advances in treatment, coordinated acute and chronic pain management, and curative therapy for children with sickle cell disease through bone marrow transplantation. The Nursing Staff on 9A and the Clinical Staff on 9C provide a caring atmosphere for the children while they are in the hospital or coming in for a chronic disease management visit; and,
WHEREAS, The Children's Hospital of Pittsburgh of UPMC Sickle Cell Program has a heart for community engagement, partnering with Children's Sickle Cell Foundation Inc. on numerous projects, including Newborn Screening Programs for sickle cell disease and sickle cell trait and educational support programs.
NOW, THEREFORE, BE IT RESOLVED that the Council of the City of Pittsburgh does hereby recognize and honor the important work of the Sickle Cell Department and their commitment to excel...
Click here for full text